PACT Priority State Impact Reports

Patients across the country will lose access to critical medicines without a technical fix. Currently, price negotiations within the Inflation Reduction Act (IRA) will cut provider reimbursement for Part B drugs. This will intensify financial pressure on independent practices, limiting providers’ ability to administer key medicines to patients while exacerbating practice closures and consolidation with more expensive hospital systems.

Select a State Below to See Why HR 4299 is Critical to Preserve Patient Access